McMurray, J. et al. (2006) Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM)-Added trial. American Heart Journal, 151, pp. 985-991. (doi: 10.1016/j.ahj.2006.02.028)
Full text not currently available from Enlighten.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | McMurray, Professor John |
| Authors: | McMurray, J., Young, J., Dunlap, M., Granger, C., Hainer, J., Michelson, E., Earle, S., Olofsson, B., Ostergren, J., Yusuf, S., Swedberg, K., Pfeffer, M., and Invest, C. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health College of Medical Veterinary and Life Sciences |
| Journal Name: | American Heart Journal |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details